Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
August 9, 2022
Patent Application Number
16419596
Date Filed
May 22, 2019
Patent Citations Received
Patent Primary Examiner
The invention describes membrane permeable creatine prodrugs, pharmaceutical compositions comprising membrane permeable creatine prodrugs, and methods of treating diseases such as ischemia, heart failure, neurodegenerative disorders and genetic disorders affecting the creatine kinase system comprising administering creatine prodrugs or pharmaceutical compositions thereof. The invention also describes treating a genetic disease affecting the creatine kinase system, such as, for example, a creatine transporter disorder or a creatine synthesis disorder comprising administering creatine prodrugs or pharmaceutical compositions thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
